EU-wide tender
Conclusion of a non-exclusive discount agreement pursuant to Section 130a (8) SGB V for the active substance Natalizumab (excl. in the Dafo. IFK), for the period 01.12.25 - 30.11.26 (incl. extension option 1x12 months)
Original title: Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Natalizumab (ausschl. in der Dafo. IFK), f. d. Zeit 01.12.25 - 30.11.26 (zzgl. Verlängerungsoption 1x12 Mon)
Wanted: Pharmaceutical products. The tender is called “Conclusion of a non-exclusive discount agreement pursuant to Section 130a (8) SGB V for the active substance Natalizumab (excl. in the Dafo. IFK), for the period 01.12.25 - 30.11.26 (incl. extension option 1x12 months)”. Offers are due by Tuesday, 5 October 2027, in 338 days. Procedure: Open procedure, published EU-wide (above the EU thresholds).
- Deadline
- 5 October 2027, 338 days left, 12:00
- Published
- 17 October 2025
- Procedure
- Open procedure
- Notice
- EU-wide (TED)
- Type of contract
- Supplies
- Estimated value
- not published
- Place of performance
- not stated
- Source, last checked
- TED, 1 November 2026
Contracting authority and documents
Contracting authority only with access
Original notice (German)Tender documents on the procurement platformIn short
A discount agreement for Natalizumab is being procured for DAK-Gesundheit.
- Non-exclusive discount agreement for the active substance Natalizumab.
- Term from 1 December 2025 to 30 November 2026.
- An extension option for twelve months is possible.
- Companies may join at any time under the same conditions.
- Offers must be submitted by email, not via the German procurement portal.
Summary made from the German notice and checked against it; the German original is authoritative.
Questions and answers
When is the deadline for offers?
Until Tuesday, 5 October 2027, 338 days left. The exact time and how to submit are in the original notice, which is authoritative.
In which language are the documents and the offer?
Expect German. The accepted languages are stated in the notice, and certificates in another language may have to be submitted with a translation.
Which rules apply?
German procurement law implementing the EU directives (GWB and VgV; for works VOB/A EU).
Is this tender open to foreign companies?
Yes. Because it is above the EU thresholds, the procedure follows the EU directives, which rule out discrimination by nationality. Suitability can first be shown with the European Single Procurement Document (ESPD).
Worth knowing before you bid
The notice links the tender documents directly. The contract runs for 12 months.
Dates of this tender
| Published | Friday, 17 October 2025 |
|---|---|
| Deadline | Tuesday, 5 October 2027, 12:00 |
| Tender validity ends (calculated) | Thursday, 4 November 2027 |
What the notice sets
| Duration | 12 months |
|---|---|
| Framework agreement | no |
| Tender validity | 1 month after the deadline |
| Suitable for SMEs | not stated |
| Security deposit | not required |
| Legal basis | GWB and VgV (German law implementing the EU directives) |
Service by CPV code
- 33600000 Pharmaceutical products
Sources
Notice: TED, Amtsblatt der Europäischen Union, retrieved 1 November 2026. All information without guarantee; the original notice is authoritative.